Tag: Selumetinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Selumetinib

New York: Array Biopharma (NASDAQ:ARRY) Stock Has Just Had Its Buy Rating Reiterated by ...

Added to Collection on: 2018-01-22 01:48:45

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Are Array BioPharma (NASDAQ:ARRY) Shares Worth Your Time and Dime Following Recent ...

Added to Collection on: 2018-01-22 21:30:00

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Array BioPharma (NASDAQ:ARRY) Receives a Higher Rating From Leerink Swann. What's The ...

Added to Collection on: 2018-01-22 21:30:00

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Are Array BioPharma (NASDAQ:ARRY) Shares a 'Buy' Now? Leerink Swann Has Upgraded The ...

Added to Collection on: 2018-01-22 21:30:00

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Will Array BioPharma Inc. (ARRY) Run Out of Steam Soon?

Added to Collection on: 2018-01-23 05:56:15

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Are Array BioPharma (NASDAQ:ARRY) Shares Headed North? Leerink Swann Issues Upgrade.

Added to Collection on: 2018-01-22 21:30:00

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Is Array BioPharma Inc. (ARRY) a Buy? The Stock Reaches Record High Today

Added to Collection on: 2018-01-23 05:56:15

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Array Biopharma (NASDAQ:ARRY): SunTrust Robinson Reconfirms “Buy” Rating Today, Has a ...

Added to Collection on: 2018-01-24 00:30:00

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
SunTrust Robinson Has Just Reaffirmed $16.0 Target Price Per Share on Array Biopharma ...

Added to Collection on: 2018-01-24 00:30:00

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Time to Reconsider Array BioPharma Inc. (ARRY) After Achieving 52-Week High?

Added to Collection on: 2018-03-07 23:11:15

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Book a Demo